Nucleic Acids On-Demand World-Wide (NOW)

Archived

DARPA - Biological Technologies Office

View on Grants.gov 📝 Build a proposal template ★ Save

Description

The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.

Who can apply

  • Others

Contact

BAA Coordinator<br/>NOW@darpa.mil
NOW@darpa.mil

Key dates & funding
  • PostedOct 16, 2019
  • ClosesJan 9, 2020
  • CFDA12.910
Categories
Science and Technology and other Research and Development

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro